Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 May;150(5):1619–1629.

Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.

I Bolon 1, M Devouassoux 1, C Robert 1, D Moro 1, C Brambilla 1, E Brambilla 1
PMCID: PMC1858196  PMID: 9137088

Abstract

We have previously shown that the extracellular-matrix-degrading enzymes, urokinase-type plasminogen activator (u-PA), stromelysin 1, stromelysin 3, and matrilysin, may play an important role in the transition from lung preneoplasia to invasive carcinoma. Using in situ hybridization and immunohistochemistry, we analyzed serial frozen sections for the expression of these enzymes in 89 lung carcinomas including 25 neuroendocrine (NE) carcinomas (10 small-cell lung carcinomas, 7 large-cell NE carcinomas, 1 atypical, and 7 typical carcinoids) and 64 non-small-cell, non-NE carcinomas (29 squamous and 7 basaloid carcinomas, 23 adenocarcinomas, and 5 large-cell carcinomas). Proteases, except matrilysin, were more often expressed in stromal than cancer cells. In non-small-cell, non-NE carcinomas, stromal co-expression of u-PA and stromelysin 3 was seen in 80 to 90% of the tumors and was highly correlated (P < 0.0001). Stromal u-PA and stromelysin 3 expression was linked to tumor size (P = 0.01 and 0.03, respectively) and lymph node involvement (P = 0.001 and 0.02, respectively). Epithelial expression of u-PA was correlated to tumor size (P = 0.04). Epithelial expression of stromelysin 3 predominated in squamous and basaloid carcinomas (P = 0.0005) and was inversely correlated to squamous differentiation (P = 0.018). Epithelial expression of matrilysin predominated in adenocarcinomas and large-cell carcinomas (P = 0.07). In NE carcinomas including small-cell lung carcinomas, stromal expression of u-PA was correlated to lymph node metastasis (P = 0.017). Epithelial expression of all enzymes were significantly less frequent in NE than in non-NE tumors. We conclude that 1) epithelial expression of matrix proteases in lung cancer is linked to cell phenotype (NE versus non-NE, squamous versus glandular) and 2) their stromal, rather than epithelial, expression influences local metastasis.

Full text

PDF
1619

Images in this article

1624Figure 1
on p.1624

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson I. C., Sugarbaker D. J., Ganju R. K., Tsarwhas D. G., Richards W. G., Sunday M., Kobzik L., Shipp M. A. Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res. 1995 Sep 15;55(18):4120–4126. [PubMed] [Google Scholar]
  2. Arrigoni M. G., Woolner L. B., Bernatz P. E. Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg. 1972 Sep;64(3):413–421. [PubMed] [Google Scholar]
  3. Baker J. B., Low D. A., Simmer R. L., Cunningham D. D. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell. 1980 Aug;21(1):37–45. doi: 10.1016/0092-8674(80)90112-9. [DOI] [PubMed] [Google Scholar]
  4. Basset P., Bellocq J. P., Wolf C., Stoll I., Hutin P., Limacher J. M., Podhajcer O. L., Chenard M. P., Rio M. C., Chambon P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990 Dec 20;348(6303):699–704. doi: 10.1038/348699a0. [DOI] [PubMed] [Google Scholar]
  5. Bolon I., Brambilla E., Vandenbunder B., Robert C., Lantuejoul S., Brambilla C. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab Invest. 1996 Jul;75(1):1–13. [PubMed] [Google Scholar]
  6. Bolon I., Gouyer V., Devouassoux M., Vandenbunder B., Wernert N., Moro D., Brambilla C., Brambilla E. Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol. 1995 Nov;147(5):1298–1310. [PMC free article] [PubMed] [Google Scholar]
  7. Brambilla E., Moro D., Veale D., Brichon P. Y., Stoebner P., Paramelle B., Brambilla C. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance. Hum Pathol. 1992 Sep;23(9):993–1003. doi: 10.1016/0046-8177(92)90260-a. [DOI] [PubMed] [Google Scholar]
  8. Buisson A. C., Gilles C., Polette M., Zahm J. M., Birembaut P., Tournier J. M. Wound repair-induced expression of a stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. Lab Invest. 1996 Mar;74(3):658–669. [PubMed] [Google Scholar]
  9. Canete-Soler R., Litzky L., Lubensky I., Muschel R. J. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol. 1994 Mar;144(3):518–527. [PMC free article] [PubMed] [Google Scholar]
  10. Engel G., Heselmeyer K., Auer G., Bäckdahl M., Eriksson E., Linder S. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer. Int J Cancer. 1994 Sep 15;58(6):830–835. doi: 10.1002/ijc.2910580614. [DOI] [PubMed] [Google Scholar]
  11. Gris J. C., Schved J. F., Marty-Double C., Mauboussin J. M., Balmes P. Immunohistochemical study of tumor cell-associated plasminogen activators and plasminogen activator inhibitors in lung carcinomas. Chest. 1993 Jul;104(1):8–13. doi: 10.1378/chest.104.1.8. [DOI] [PubMed] [Google Scholar]
  12. Kobayashi H., Fujishiro S., Terao T. Impact of urokinase-type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res. 1994 Dec 15;54(24):6539–6548. [PubMed] [Google Scholar]
  13. Kristensen P., Eriksen J., Danø K. Localization of urokinase-type plasminogen activator messenger RNA in the normal mouse by in situ hybridization. J Histochem Cytochem. 1991 Mar;39(3):341–349. doi: 10.1177/39.3.1899685. [DOI] [PubMed] [Google Scholar]
  14. Lefebvre O., Wolf C., Limacher J. M., Hutin P., Wendling C., LeMeur M., Basset P., Rio M. C. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis. J Cell Biol. 1992 Nov;119(4):997–1002. doi: 10.1083/jcb.119.4.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lorimier P., Lamarcq L., Labat-Moleur F., Guillermet C., Bethier R., Stoebner P. Enhanced chemiluminescence: a high-sensitivity detection system for in situ hybridization and immunohistochemistry. J Histochem Cytochem. 1993 Nov;41(11):1591–1597. doi: 10.1177/41.11.7691929. [DOI] [PubMed] [Google Scholar]
  16. Low D. A., Baker J. B., Koonce W. C., Cunningham D. D. Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2340–2344. doi: 10.1073/pnas.78.4.2340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Markus G., Takita H., Camiolo S. M., Corasanti J. G., Evers J. L., Hobika G. H. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res. 1980 Mar;40(3):841–848. [PubMed] [Google Scholar]
  18. McDonnell S., Navre M., Coffey R. J., Jr, Matrisian L. M. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog. 1991;4(6):527–533. doi: 10.1002/mc.2940040617. [DOI] [PubMed] [Google Scholar]
  19. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev. 1993 Jan;73(1):161–195. doi: 10.1152/physrev.1993.73.1.161. [DOI] [PubMed] [Google Scholar]
  20. Moro D., Brichon P. Y., Brambilla E., Veale D., Labat F., Brambilla C. Basaloid bronchial carcinoma. A histologic group with a poor prognosis. Cancer. 1994 Jun 1;73(11):2734–2739. doi: 10.1002/1097-0142(19940601)73:11<2734::aid-cncr2820731114>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  21. Muller D., Breathnach R., Engelmann A., Millon R., Bronner G., Flesch H., Dumont P., Eber M., Abecassis J. Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer. 1991 Jun 19;48(4):550–556. doi: 10.1002/ijc.2910480412. [DOI] [PubMed] [Google Scholar]
  22. Muller D., Quantin B., Gesnel M. C., Millon-Collard R., Abecassis J., Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J. 1988 Jul 1;253(1):187–192. doi: 10.1042/bj2530187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nagayama M., Sato A., Hayakawa H., Urano T., Takada Y., Takada A. Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination. Cancer. 1994 Mar 1;73(5):1398–1405. doi: 10.1002/1097-0142(19940301)73:5<1398::aid-cncr2820730514>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  24. Oka T., Ishida T., Nishino T., Sugimachi K. Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res. 1991 Jul 1;51(13):3522–3525. [PubMed] [Google Scholar]
  25. Ornstein D. L., Zacharski L. R., Memoli V. A., Kisiel W., Kudryk B. J., Hunt J., Rousseau S. M., Stump D. C. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues. Cancer. 1991 Sep 1;68(5):1061–1067. doi: 10.1002/1097-0142(19910901)68:5<1061::aid-cncr2820680525>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  26. Pedersen H., Brünner N., Francis D., Osterlind K., Rønne E., Hansen H. H., Danø K., Grøndahl-Hansen J. Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res. 1994 Sep 1;54(17):4671–4675. [PubMed] [Google Scholar]
  27. Pedersen H., Grøndahl-Hansen J., Francis D., Osterlind K., Hansen H. H., Danø K., Brünner N. Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma. Cancer Res. 1994 Jan 1;54(1):120–123. [PubMed] [Google Scholar]
  28. Pei D., Majmudar G., Weiss S. J. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem. 1994 Oct 14;269(41):25849–25855. [PubMed] [Google Scholar]
  29. Pei D., Weiss S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature. 1995 May 18;375(6528):244–247. doi: 10.1038/375244a0. [DOI] [PubMed] [Google Scholar]
  30. Pyke C., Graem N., Ralfkiaer E., Rønne E., Høyer-Hansen G., Brünner N., Danø K. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res. 1993 Apr 15;53(8):1911–1915. [PubMed] [Google Scholar]
  31. Pyke C., Kristensen P., Ralfkiaer E., Grøndahl-Hansen J., Eriksen J., Blasi F., Danø K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol. 1991 May;138(5):1059–1067. [PMC free article] [PubMed] [Google Scholar]
  32. Pyke C., Ralfkiaer E., Rønne E., Høyer-Hansen G., Kirkeby L., Danø K. Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology. 1994 Feb;24(2):131–138. doi: 10.1111/j.1365-2559.1994.tb01291.x. [DOI] [PubMed] [Google Scholar]
  33. Rouyer N., Wolf C., Chenard M. P., Rio M. C., Chambon P., Bellocq J. P., Basset P. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis. 1994;14(1-6):269–275. [PubMed] [Google Scholar]
  34. Saarialho-Kere U. K., Crouch E. C., Parks W. C. Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol. 1995 Aug;105(2):190–196. doi: 10.1111/1523-1747.ep12317104. [DOI] [PubMed] [Google Scholar]
  35. Santavicca M., Noel A., Chenard M. P., Lutz Y., Stoll I., Segain J. P., Rouyer N., Rio M. C., Wolf C., Belloco J. P. Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry. Int J Cancer. 1995 Oct 20;64(5):336–341. doi: 10.1002/ijc.2910640510. [DOI] [PubMed] [Google Scholar]
  36. Sappino A. P., Busso N., Belin D., Vassalli J. D. Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res. 1987 Aug 1;47(15):4043–4046. [PubMed] [Google Scholar]
  37. Travis W. D., Linnoila R. I., Tsokos M. G., Hitchcock C. L., Cutler G. B., Jr, Nieman L., Chrousos G., Pass H., Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol. 1991 Jun;15(6):529–553. doi: 10.1097/00000478-199106000-00003. [DOI] [PubMed] [Google Scholar]
  38. Urbanski S. J., Edwards D. R., Maitland A., Leco K. J., Watson A., Kossakowska A. E. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer. 1992 Dec;66(6):1188–1194. doi: 10.1038/bjc.1992.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Vandenbunder B., Pardanaud L., Jaffredo T., Mirabel M. A., Stehelin D. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development. 1989 Oct;107(2):265–274. doi: 10.1242/dev.107.2.265. [DOI] [PubMed] [Google Scholar]
  40. Veale D., Needham G., Harris A. L. Urokinase receptors in lung cancer and normal lung. Anticancer Res. 1990 Mar-Apr;10(2A):417–421. [PubMed] [Google Scholar]
  41. Visscher D. W., Sarkar F., LoRusso P., Sakr W., Ottosen S., Wykes S., Crissman J. D. Immunohistologic evaluation of invasion-associated proteases in breast carcinoma. Mod Pathol. 1993 May;6(3):302–306. [PubMed] [Google Scholar]
  42. Wolf C., Rouyer N., Lutz Y., Adida C., Loriot M., Bellocq J. P., Chambon P., Basset P. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1843–1847. doi: 10.1073/pnas.90.5.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES